Clinical Trials | February 21, 2023
Redcliffe Labs launches BD MAX MDR TB test for MDR-TB in a Single test
Becomes the 1st diagnostics company in India to launch BD MAX MDR TB test
Becomes the 1st diagnostics company in India to launch BD MAX MDR TB test
The company has also been named among global sustainability leaders for the 7th year in a row in the Dow Jones Sustainability Index in the Emerging Markets category
The forecast across the seven years between 2022 and 2028 saw an average decline of 7%, resulting in a $10 billion drop in the total forecast sales between 2021 and 2028
On the day dedicated to the battle against the deadly disease – took to reaching the public of Pune to understand that cancer can be prevented and even reversed with the help of adequate testing
The initiative launched in 2019 has touched over 10,000 lives with 500+ screening camps and aims to double its reach in the next 2 years
The company will not receive any proceeds from the offer as all of it will go to the promoter selling shareholder.
Exceeding the target of 1.50 lakh Ayushman Bharat - Health & Wellness Centres (AB-HWC) by 31 December, 2022, more than 1.54 lakh Sub Health Centres and Primary Health Centres have been transformed as AB-HWCs
This ambitious anti-TB campaign, as part of IOCL’s CSR, aims to ensure early identification of presumptive TB and prompt diagnosis using high-sensitivity diagnostic tests at the doorstep
China is now focusing on establishing volume and enhancing capabilities for innovative high value drug production
GlobalData predicts the average prices of dual chamber pacemakers in both India and China are expected to reduce at an average CAGR of -3.42% from 2022 to 2025.
Subscribe To Our Newsletter & Stay Updated
